Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
Sales | 156 | 4,131 | 1,517 | 268 | 967 |
Gross Profit | 156 | 4,131 | 1,517 | 268 | 967 |
Operating Expenses | 40,764 | 51,758 | 42,756 | 33,473 | 33,438 |
Operating Income | -40,608 | -47,627 | -41,239 | -33,205 | -32,471 |
Other Income | 7,800 | 4,321 | 2,979 | 2,703 | 3,110 |
Pre-tax Income | -32,808 | -43,306 | -38,260 | -30,502 | -29,361 |
Net Income Continuous | -32,808 | -43,306 | -38,260 | -30,502 | -29,361 |
Net Income | $-32,808 | $-43,306 | $-38,260 | $-30,502 | $-29,361 |
EPS Basic Total Ops | -0.56 | -0.84 | -0.81 | -0.65 | -0.62 |
EPS Basic Continuous Ops | -0.56 | -0.84 | -0.81 | -0.65 | -0.62 |
EPS Diluted Total Ops | -0.56 | -0.84 | -0.81 | -0.65 | -0.62 |
EPS Diluted Continuous Ops | -0.56 | -0.84 | -0.81 | -0.65 | -0.62 |
EPS Diluted Before Non-Recurring Items | N/A | -0.57 | -0.81 | -0.65 | -0.62 |
EBITDA(a) | $-43,146 | $-49,047 | $-42,099 | $-33,609 | $-33,001 |